Edition:
United Kingdom

Chembio Diagnostics Inc (CEMI.OQ)

CEMI.OQ on NASDAQ Stock Exchange Capital Market

9.20USD
4:34pm BST
Change (% chg)

$-0.30 (-3.16%)
Prev Close
$9.50
Open
$9.30
Day's High
$9.45
Day's Low
$9.10
Volume
5,550
Avg. Vol
6,428
52-wk High
$11.55
52-wk Low
$5.85

Chart for

About

Chembio Diagnostics, Inc. (Chembio), and its subsidiary, Chembio Diagnostic Systems, Inc., develop, manufacture, market and license rapid point-of-care diagnostic tests (POCTs) that detect infectious diseases. The Company's products available are rapid tests for the detection of human immunodeficiency virus (HIV) 1/2 antibodies,... (more)

Overall

Beta: 1.19
Market Cap(Mil.): $77.55
Shares Outstanding(Mil.): 12.31
Dividend: --
Yield (%): --

Financials

  CEMI.OQ Industry Sector
P/E (TTM): -- 30.93 32.76
EPS (TTM): -0.71 -- --
ROI: -68.16 15.07 14.61
ROE: -69.09 16.59 16.33

BRIEF-Chembio Diagnostics Reports Q1 Loss Per Share $0.05

* CHEMBIO DIAGNOSTICS REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS

09 May 2018

BRIEF-Chembio Diagnostics And Lumiradx Enter Collaboration To Develop New Point-Of-Care Diagnostic Tests For Infectious Diseases

* CHEMBIO DIAGNOSTICS AND LUMIRADX ENTER COLLABORATION TO DEVELOP NEW POINT-OF-CARE DIAGNOSTIC TESTS FOR INFECTIOUS DISEASES

25 Apr 2018

Competitors

Earnings vs. Estimates